Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 14, 2026 08:00 ET | Source: Er-Kim Pharmaceuticals

Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers

Er-Kim and LEO Pharma A/S sign exclusive agreement to launch LOQTORZI® across Central and Eastern Europe, expanding access to innovative cancer treatment